Search research articles
Contact Us
Filters
Showing results (61-70 of 122) with videos related to
Page
of 13
Sort By:
British Journal of Haematology
|
July 18, 2020
Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience
Katharine L Lewis, Collin K Chin, Kate Manos, et al.
The Lancet. Oncology
|
September 2, 2022
CNS prophylaxis for diffuse large B-cell lymphoma
Toby A Eyre, Kerry J Savage, Chan Y Cheah, et al.
Annals of Hematology
|
March 6, 2014
Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy
Chan Y Cheah, Michael Dickinson, Michael S Hofman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2023
High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma
Katharine L Lewis, Lasse H Jakobsen, Diego Villa, et al.
Leukemia & Lymphoma
|
April 15, 2014
The utility and limitations of (18)F-fluorodeoxyglucose positron emission tomography with computed tomography in patients with primary mediastinal B-cell lymphoma: single institution experience and literature review
Chan Y Cheah, Michael S Hofman, John F Seymour, et al.
Future Oncology (London, England)
|
November 15, 2022
BRUIN MCL-321: phase III study of pirtobrutinib versus investigator choice of BTK inhibitor in BTK inhibitor naive mantle cell lymphoma
Toby A Eyre, Nirav N Shah, Martin Dreyling, et al.
British Journal of Haematology
|
December 10, 2015
Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center
Dai Chihara, Chan Y Cheah, Jason R Westin, et al.
British Journal of Haematology
|
May 6, 2025
An international real-world study of primary vitreoretinal lymphoma from the Australasian lymphoma alliance and collaborators
Catherine Tang, Catriona Downie, Mandeep S Sagoo, et al.
Blood
|
October 26, 2023
CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC study
Adrian Minson, Nada Hamad, Chan Y Cheah, et al.
Blood Advances
|
February 5, 2026
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory Richter's transformation
Katharine Louise Lewis, Sarit E Assouline, Ross Ian Baker, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 122) with videos related to
Sort By:
Page
of 13
British Journal of Haematology
|
July 18, 2020
Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience
Katharine L Lewis, Collin K Chin, Kate Manos, et al.
The Lancet. Oncology
|
September 2, 2022
CNS prophylaxis for diffuse large B-cell lymphoma
Toby A Eyre, Kerry J Savage, Chan Y Cheah, et al.
Annals of Hematology
|
March 6, 2014
Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy
Chan Y Cheah, Michael Dickinson, Michael S Hofman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2023
High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma
Katharine L Lewis, Lasse H Jakobsen, Diego Villa, et al.
Leukemia & Lymphoma
|
April 15, 2014
The utility and limitations of (18)F-fluorodeoxyglucose positron emission tomography with computed tomography in patients with primary mediastinal B-cell lymphoma: single institution experience and literature review
Chan Y Cheah, Michael S Hofman, John F Seymour, et al.
Future Oncology (London, England)
|
November 15, 2022
BRUIN MCL-321: phase III study of pirtobrutinib versus investigator choice of BTK inhibitor in BTK inhibitor naive mantle cell lymphoma
Toby A Eyre, Nirav N Shah, Martin Dreyling, et al.
British Journal of Haematology
|
December 10, 2015
Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center
Dai Chihara, Chan Y Cheah, Jason R Westin, et al.
British Journal of Haematology
|
May 6, 2025
An international real-world study of primary vitreoretinal lymphoma from the Australasian lymphoma alliance and collaborators
Catherine Tang, Catriona Downie, Mandeep S Sagoo, et al.
Blood
|
October 26, 2023
CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC study
Adrian Minson, Nada Hamad, Chan Y Cheah, et al.
Blood Advances
|
February 5, 2026
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory Richter's transformation
Katharine Louise Lewis, Sarit E Assouline, Ross Ian Baker, et al.
Page
of 13